LabStyle Innovations has received Health Canada approval for its Dario diabetes management solution, allowing to market it in the country.
Dario is a platform that aggregates blood glucose meter, smart phone application (iOS andAndroid), website application and treatment tools to support patients, doctors and healthcare systems with proactive and better informed decisions.
The company has developed Dario to spot patterns, recommend the right treatments and support behavior change efforts.
Medical devices supplier Auto Control Medical (ACM) will exclusively distribute Dario diabetes management solution in Canada.
LabStyle Innovations president and CEO Erez Raphael said: "Health Canada approval marks an important next step as we continue to expand the geographic reach of the Dario diabetes management solution to the world’s huge population of people with Diabetes in order to help make their lives simpler while treating their chronic condition."
LabStyle has completed and submitted the Dario blood glucose monitoring system clinical study results to the FDA for review.